Product description
| Symbol | Cusip | Name | Amount | Value | Title Of Class | Pay of profile | |
|---|---|---|---|---|---|---|---|
| 09062X103 | 09062X103 | Biogen Inc | 56.0 | 13108.48 | CORP | Long | |
| 28106W103 | 28106W103 | Editas Medicine Inc | 14406.0 | 151695.18 | CORP | Long | |
| 31846V328 | 31846V328 | First American Treasury Obliga | 4849.59 | 4849.59 | RF | Long | |
| 452327109 | 452327109 | Illumina Inc | 308.0 | 31400.6 | CORP | Long | |
| N/A | N/A | Novartis AG | 812.0 | 79486.45 | CORP | Long | |
| 92539P101 | 92539P101 | Verve Therapeutics Inc | 9968.0 | 112439.04 | CORP | Long | |
| N/A | N/A | Sanofi SA | 910.0 | 84852.97 | CORP | Long | |
| 800677106 | 800677106 | Sangamo Therapeutics Inc | 101500.0 | 43645.0 | CORP | Long | |
| 883556102 | 883556102 | Thermo Fisher Scientific Inc | 518.0 | 256803.68 | CORP | Long | |
| N/A | N/A | CRISPR Therapeutics AG | 5698.0 | 380227.54 | CORP | Long | |
| N/A | N/A | QIAGEN NV | 448.0 | 18439.68 | CORP | Long | |
| 00846U101 | 00846U101 | Agilent Technologies Inc | 574.0 | 73357.2 | CORP | Long | |
| 019770106 | 019770106 | Allogene Therapeutics Inc | 32998.0 | 77545.3 | CORP | Long | |
| 45826J105 | 45826J105 | Intellia Therapeutics Inc | 7616.0 | 225662.08 | CORP | Long | |
| 00287Y109 | 00287Y109 | AbbVie Inc | 728.0 | 103659.92 | CORP | Long | |
| 07373V105 | 07373V105 | Beam Therapeutics Inc | 12306.0 | 345552.48 | CORP | Long | |
| 110122108 | 110122108 | Bristol-Myers Squibb Co | 854.0 | 42170.52 | CORP | Long | |
| 142038108 | 142038108 | Caribou Biosciences Inc | 21784.0 | 127872.08 | CORP | Long | |
| 31846V336 | 31846V336 | First American Government Obli | 4849.59 | 4849.59 | RF | Long | |
| 74019P108 | 74019P108 | Precision BioSciences Inc | 62664.0 | 22251.99 | CORP | Long | |
| 74168J101 | 74168J101 | Prime Medicine Inc | 21546.0 | 156423.96 | CORP | Long | |
| 901384107 | 901384107 | 2seventy bio Inc | 24724.0 | 45244.92 | CORP | Long | |
| 92532F100 | 92532F100 | Vertex Pharmaceuticals Inc | 112.0 | 39738.72 | CORP | Long | |
| 75886F107 | 75886F107 | Regeneron Pharmaceuticals Inc | 42.0 | 34600.02 | CORP | Long | |
| 73730P108 | 73730P108 | Poseida Therapeutics Inc | 41412.0 | 110570.04 | CORP | Long |